These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16971342)

  • 1. Metabolism of N-substituted 7-methoxy-4-(aminomethyl) -coumarins by cytochrome P450 2D6 mutants and the indication of additional substrate interaction points.
    Keizers PH; Van Dijk BR; De Graaf C; Van Vugt-Lussenburg BM; Vermeulen NP; Commandeur JN
    Xenobiotica; 2006 Sep; 36(9):763-71. PubMed ID: 16971342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent.
    Lussenburg BM; Keizers PH; de Graaf C; Hidestrand M; Ingelman-Sundberg M; Vermeulen NP; Commandeur JN
    Biochem Pharmacol; 2005 Oct; 70(8):1253-61. PubMed ID: 16135359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity.
    Venhorst J; Onderwater RC; Meerman JH; Commandeur JN; Vermeulen NP
    Drug Metab Dispos; 2000 Dec; 28(12):1524-32. PubMed ID: 11095593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and characterization of 7-methoxy-4-(aminomethyl)coumarin as a novel and selective cytochrome P450 2D6 substrate suitable for high-throughput screening.
    Onderwater RC; Venhorst J; Commandeur JN; Vermeulen NP
    Chem Res Toxicol; 1999 Jul; 12(7):555-9. PubMed ID: 10409393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism.
    Keizers PH; Lussenburg BM; de Graaf C; Mentink LM; Vermeulen NP; Commandeur JN
    Biochem Pharmacol; 2004 Dec; 68(11):2263-71. PubMed ID: 15498516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coumarin substrates for cytochrome P450 2D6 fluorescence assays.
    Nakamura K; Hanna IH; Cai H; Nishimura Y; Williams KM; Guengerich FP
    Anal Biochem; 2001 May; 292(2):280-6. PubMed ID: 11355862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 7-methoxy-4-(aminomethyl)-coumarin to wild-type and W128F mutant cytochrome P450 2D6 studied by time-resolved fluorescence spectroscopy.
    Stortelder A; Keizers PH; Oostenbrink C; De Graaf C; De Kruijf P; Vermeulen NP; Gooijer C; Commandeur JN; Van der Zwan G
    Biochem J; 2006 Feb; 393(Pt 3):635-43. PubMed ID: 16190863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis.
    Guengerich FP; Hanna IH; Martin MV; Gillam EM
    Biochemistry; 2003 Feb; 42(5):1245-53. PubMed ID: 12564927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.
    Flanagan JU; Maréchal JD; Ward R; Kemp CA; McLaughlin LA; Sutcliffe MJ; Roberts GC; Paine MJ; Wolf CR
    Biochem J; 2004 Jun; 380(Pt 2):353-60. PubMed ID: 14992686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Kemp CA; Flanagan JU; van Eldik AJ; Maréchal JD; Wolf CR; Roberts GC; Paine MJ; Sutcliffe MJ
    J Med Chem; 2004 Oct; 47(22):5340-6. PubMed ID: 15481972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy.
    Bonifacio A; Keizers PH; Commandeur JN; Vermeulen NP; Robert B; Gooijer C; van der Zwan G
    Biochem Biophys Res Commun; 2006 May; 343(3):772-9. PubMed ID: 16563352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topological role of cytochrome P450 2D6 active site residues.
    van Waterschoot RA; Keizers PH; de Graaf C; Vermeulen NP; Tschirret-Guth RA
    Arch Biochem Biophys; 2006 Mar; 447(1):53-8. PubMed ID: 16466686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation.
    Keizers PH; de Graaf C; de Kanter FJ; Oostenbrink C; Feenstra KA; Commandeur JN; Vermeulen NP
    J Med Chem; 2005 Sep; 48(19):6117-27. PubMed ID: 16162012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel high-throughput assay for cytochrome P450 2D6 using 7-methoxy-4-(aminomethyl)-coumarin.
    Venhorst J; Onderwater RC; Meerman JH; Vermeulen NP; Commandeur JN
    Eur J Pharm Sci; 2000 Dec; 12(2):151-8. PubMed ID: 11102743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: the role of aspartate 301 in structural integrity.
    Hanna IH; Kim MS; Guengerich FP
    Arch Biochem Biophys; 2001 Sep; 393(2):255-61. PubMed ID: 11556812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6.
    Keizers PH; Schraven LH; de Graaf C; Hidestrand M; Ingelman-Sundberg M; van Dijk BR; Vermeulen NP; Commandeur JN
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1065-74. PubMed ID: 16269134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CYP2D6 substrate interactions by computational methods.
    Ito Y; Kondo H; Goldfarb PS; Lewis DF
    J Mol Graph Model; 2008 Feb; 26(6):947-56. PubMed ID: 17764997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6.
    Kirton SB; Kemp CA; Tomkinson NP; St-Gallay S; Sutcliffe MJ
    Proteins; 2002 Nov; 49(2):216-31. PubMed ID: 12211002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation.
    Lisurek M; Simgen B; Antes I; Bernhardt R
    Chembiochem; 2008 Jun; 9(9):1439-49. PubMed ID: 18481342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double site saturation mutagenesis of the human cytochrome P450 2D6 results in regioselective steroid hydroxylation.
    Geier M; Braun A; Fladischer P; Stepniak P; Rudroff F; Hametner C; Mihovilovic MD; Glieder A
    FEBS J; 2013 Jul; 280(13):3094-108. PubMed ID: 23552177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.